These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 24087965)

  • 1. [The differences between the guidelines of the European Society of Cardiology and the American College of Cardiology/ American Heart Association for oral P2Y12 inhibitor therapy in the management of patients with acute coronary syndromes].
    Serebruany VL; Pershukov IV
    Kardiologiia; 2013; 53(7):70-7. PubMed ID: 24087965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viewpoint: mismatch between the European and American guidelines on oral antiplatelet P2Y12 inhibitors after acute coronary syndromes.
    Serebruany VL; DiNicolantonio JJ
    Thromb Haemost; 2013 Jul; 110(1):5-10. PubMed ID: 23743577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the American College of Cardiology/American Heart Association and the European Society of Cardiology guidelines for the management of patients with non-ST-segment elevation acute coronary syndromes.
    Alame AJ; Karatasakis A; Karacsonyi J; Danek BA; Resendes E; Martinez Parachini JR; Kalsaria P; Roesle M; Rangan BV; Sorajja P; Jneid H; Banerjee S; Brilakis ES
    Coron Artery Dis; 2017 Jun; 28(4):294-300. PubMed ID: 28306587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updates and current recommendations for the management of patients with non-ST-elevation acute coronary syndromes: what it means for clinical practice.
    Cayla G; Silvain J; Collet JP; Montalescot G
    Am J Cardiol; 2015 Mar; 115(5 Suppl):10A-22A. PubMed ID: 25728969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC Guidelines.
    Rodriguez F; Mahaffey KW
    J Am Coll Cardiol; 2016 Jul; 68(3):313-321. PubMed ID: 27417010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of new P2Y12 inhibitors: selection of P2Y12 inhibitors in clinical practice.
    Golino P
    J Cardiovasc Med (Hagerstown); 2013 Dec; 14 Suppl 1():S22-30. PubMed ID: 24378838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiplatelet therapy after acute coronary syndrome. Therapeutic strategies and treatment duration].
    Olivier CB; Diehl P; Bode C; Moser M
    Herz; 2014 Nov; 39(7):808-13. PubMed ID: 25359405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of non-ST-segment elevation acute coronary syndrome: comparison of the updated guidelines from North America and Europe.
    Thomas D; Giugliano RP
    Crit Pathw Cardiol; 2012 Jun; 11(2):62-73. PubMed ID: 22595816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of acute coronary syndrome in the hospital: a focus on ACCF/AHA guideline updates to oral antiplatelet therapy.
    Vengoechea F
    Hosp Pract (1995); 2014 Aug; 42(3):33-47. PubMed ID: 25255405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving pattern of platelet P2Y12 inhibition in patients with acute coronary syndromes.
    Joshi RR; Hossain R; Morton AC; Ecob R; Judge HM; Wales C; Walker JV; Karunakaran A; Storey RF
    Platelets; 2014; 25(6):416-22. PubMed ID: 24111601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet and Anticoagulation Treatment in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome: Comparison of the Updated North American and European Guidelines.
    Eisen A; Giugliano RP
    Cardiol Rev; 2016; 24(4):170-6. PubMed ID: 26186386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antiplatelet agents in the treatment of acute coronary syndromes.
    Sabouret P; Taiel-Sartral M
    Arch Cardiovasc Dis; 2014 Mar; 107(3):178-87. PubMed ID: 24630752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A model-based analysis of the clinical and economic impact of personalising P2Y12-receptor inhibition with platelet function testing in acute coronary syndrome patients.
    Straub N; Beivers A; Lenk E; Aradi D; Sibbing D
    Thromb Haemost; 2014 Feb; 111(2):290-9. PubMed ID: 24154566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging oral antiplatelet therapies for acute coronary syndromes.
    Pollack CV
    Hosp Pract (1995); 2010 Nov; 38(4):29-37. PubMed ID: 21068524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
    Levine GN; Bates ER; Bittl JA; Brindis RG; Fihn SD; Fleisher LA; Granger CB; Lange RA; Mack MJ; Mauri L; Mehran R; Mukherjee D; Newby LK; O'Gara PT; Sabatine MS; Smith PK; Smith SC
    Circulation; 2016 Sep; 134(10):e123-55. PubMed ID: 27026020
    [No Abstract]   [Full Text] [Related]  

  • 16. Ticagrelor, prasugrel, or clopidogrel in ST-segment elevation myocardial infarction: which one to choose?
    Guimarães PO; Tricoci P
    Expert Opin Pharmacother; 2015; 16(13):1983-95. PubMed ID: 26224244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eligibility for PCSK9 Inhibitors According to American College of Cardiology (ACC) and European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Guidelines After Acute Coronary Syndromes.
    Gencer B; Koskinas KC; Räber L; Karagiannis A; Nanchen D; Auer R; Carballo D; Carballo S; Klingenberg R; Heg D; Matter CM; Lüscher TF; Rodondi N; Mach F; Windecker S
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative management of dual anti-platelet therapy.
    Webster TD; Vaishnava P; Eagle KA
    Hosp Pract (1995); 2016 Dec; 44(5):237-241. PubMed ID: 27846735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of optimal P2Y12-ADP receptor blockade after ticagrelor and prasugrel intake in Non-ST elevation acute coronary syndrome.
    Bonello L; Laine M; Camoin-Jau L; Noirot F; Guieu R; Dignat-George F; Paganelli F; Frere C
    Thromb Haemost; 2015 Oct; 114(4):702-7. PubMed ID: 26311415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSTE-ACS ESC Guidelines Recommend Prasugrel as the Preferred P2Y12 Inhibitor: A Contrarian View.
    Angoulvant D; Sabouret P; Savage MP
    Am J Cardiovasc Drugs; 2021 Sep; 21(5):483-486. PubMed ID: 33674980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.